Competitive PCR to detect eIF4E gene amplification in head and neck cancer
- PMID: 9890352
- DOI: 10.1002/(sici)1097-0347(199901)21:1<60::aid-hed8>3.0.co;2-j
Competitive PCR to detect eIF4E gene amplification in head and neck cancer
Abstract
Background: The protein eukaryotic initiation factor 4E (elF4E) binds to messenger ribonucleic acid (mRNA) as the initial step in protein synthesis. Overexpression of elF4E results in upregulation of specific proteins essential to cell growth and division. Overexpression of elF4E has been found in head and neck squamous cell carcinoma (HNSCC) and breast carcinoma. This study's purpose is to determine whether elF4E overexpression is present and associated with elF4E gene amplification in HNSCC.
Methods: Competitive polymerase chain reaction (PCR) was performed on eight HNSCC and seven intraoral benign lesions to determine the copy number of elF4E relative to a reference gene, gastrin. Western blots were performed to quantify elF4E protein expression.
Results: All eight HNSCC specimens demonstrated significant (p < .005) overexpression of elF4E protein (14.1+/-10.4) and elF4E gene amplification (4.5+/-1.2). Benign tissue did not exhibit elF4E protein overexpression or gene amplification.
Conclusions: Overexpression and associated gene amplification of elF4E were present in HNSCC but not in benign tissue. Gene amplification of elF4E may be an important mechanism for elF4E overexpression.
Similar articles
-
Pattern of amplification and overexpression of the eukaryotic initiation factor 4E gene in solid tumor.J Surg Res. 1999 Jul;85(1):37-42. doi: 10.1006/jsre.1999.5653. J Surg Res. 1999. PMID: 10383835
-
Progressive amplification and overexpression of the eukaryotic initiation factor 4E gene in different zones of head and neck cancers.J Oral Maxillofac Surg. 1999 Mar;57(3):294-9. doi: 10.1016/s0278-2391(99)90676-6. J Oral Maxillofac Surg. 1999. PMID: 10077200
-
Detection of eIF4E gene amplification in breast cancer by competitive PCR.Ann Surg Oncol. 1998 Apr-May;5(3):232-7. doi: 10.1007/BF02303778. Ann Surg Oncol. 1998. PMID: 9607624
-
eIF4E expression in tumors: its possible role in progression of malignancies.Int J Biochem Cell Biol. 1999 Jan;31(1):59-72. doi: 10.1016/s1357-2725(98)00132-0. Int J Biochem Cell Biol. 1999. PMID: 10216944 Review.
-
Expression of eIF4E during head and neck tumorigenesis: possible role in angiogenesis.Laryngoscope. 1999 Aug;109(8):1253-8. doi: 10.1097/00005537-199908000-00013. Laryngoscope. 1999. PMID: 10443829 Review.
Cited by
-
Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap.Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18105-10. doi: 10.1073/pnas.0406927102. Epub 2004 Dec 15. Proc Natl Acad Sci U S A. 2004. PMID: 15601771 Free PMC article.
-
Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer.J Oncol. 2009;2009:981679. doi: 10.1155/2009/981679. Epub 2009 Dec 13. J Oncol. 2009. PMID: 20049173 Free PMC article.
-
mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer.ISRN Otolaryngol. 2012 Oct 18;2012:953089. doi: 10.5402/2012/953089. Print 2012. ISRN Otolaryngol. 2012. PMID: 23762622 Free PMC article.
-
Deep computational analysis details dysregulation of eukaryotic translation initiation complex eIF4F in human cancers.Cell Syst. 2021 Sep 22;12(9):907-923.e6. doi: 10.1016/j.cels.2021.07.002. Epub 2021 Aug 5. Cell Syst. 2021. PMID: 34358439 Free PMC article.
-
The oncogene eIF4E: using biochemical insights to target cancer.J Interferon Cytokine Res. 2013 May;33(5):227-38. doi: 10.1089/jir.2012.0142. Epub 2013 Mar 8. J Interferon Cytokine Res. 2013. PMID: 23472659 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical